PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
BackgroundThere is increasing evidence that group 2 innate lymphoid cells (ILC2s) play an essential role in allergy and parasitic infection. However, the role of ILC2s in human lung cancer remains unclear.MethodsILC2s from peripheral blood mononuclear cells (PBMCs) obtained from healthy donors (HDs)...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.680055/full |
id |
doaj-d736f4099110474eb74b7d58943360db |
---|---|
record_format |
Article |
spelling |
doaj-d736f4099110474eb74b7d58943360db2021-06-14T15:28:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-06-011210.3389/fimmu.2021.680055680055PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung CancerChunyi Shen0Chaojun Liu1Zhen Zhang2Zhen Zhang3Yu Ping4Jingwen Shao5Yonggui Tian6Weina Yu7Guohui Qin8Guohui Qin9Shasha Liu10Liping Wang11Yi Zhang12Yi Zhang13Yi Zhang14Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaState Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaState Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBiotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaState Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, ChinaHenan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, ChinaBackgroundThere is increasing evidence that group 2 innate lymphoid cells (ILC2s) play an essential role in allergy and parasitic infection. However, the role of ILC2s in human lung cancer remains unclear.MethodsILC2s from peripheral blood mononuclear cells (PBMCs) obtained from healthy donors (HDs) and non-small cell lung cancer (NSCLC) patients, and NSCLC tumor tissues were analyzed via multicolor flow cytometry. ILC2s or CD14+ cells were sorted by fluorescence-activated cell sorting. qPCR and flow cytometry were performed to assess the gene and protein expression of the indicated molecules. M1-like and M2-like macrophages were induced from CD14+ monocytes in vitro.ResultsILC2s were significantly more enriched in PBMCs and tumor tissues from NSCLC patients than in HDs. After screening for the main immune checkpoint molecules, we found that PD-1 was upregulated in ILC2s in NSCLC patients. Functionally, PD-1high ILC2s from tumor tissues expressed higher levels of IL-4 and IL-13 regarding both mRNA and protein levels than PD-1low ILC2s. Furthermore, PD-1high ILC2s robustly boosted M2-like macrophage polarization in vitro, by secreting IL-4 and IL-13, while neutralization of IL-4 and IL-13 by antibodies abrogated M2-like macrophage polarization.ConclusionILC2s are enriched in NSCLC patients and upregulate PD-1 expression. Upregulation of PD-1 facilitates the immunosuppressive function of ILC2s. PD-1high ILC2s enhance M2-like macrophage polarization by secreting IL-4 and IL-13. PD-1 acts as a positive regulator of the immunosuppressive function of ILC2s in human NSCLC.https://www.frontiersin.org/articles/10.3389/fimmu.2021.680055/fullinnate immune responsenon-small cell lung cancerprogrammed cell death protein 1group 2 innate lymphoid cellstype 2 macrophage |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chunyi Shen Chaojun Liu Zhen Zhang Zhen Zhang Yu Ping Jingwen Shao Yonggui Tian Weina Yu Guohui Qin Guohui Qin Shasha Liu Liping Wang Yi Zhang Yi Zhang Yi Zhang |
spellingShingle |
Chunyi Shen Chaojun Liu Zhen Zhang Zhen Zhang Yu Ping Jingwen Shao Yonggui Tian Weina Yu Guohui Qin Guohui Qin Shasha Liu Liping Wang Yi Zhang Yi Zhang Yi Zhang PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer Frontiers in Immunology innate immune response non-small cell lung cancer programmed cell death protein 1 group 2 innate lymphoid cells type 2 macrophage |
author_facet |
Chunyi Shen Chaojun Liu Zhen Zhang Zhen Zhang Yu Ping Jingwen Shao Yonggui Tian Weina Yu Guohui Qin Guohui Qin Shasha Liu Liping Wang Yi Zhang Yi Zhang Yi Zhang |
author_sort |
Chunyi Shen |
title |
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer |
title_short |
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer |
title_full |
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer |
title_fullStr |
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer |
title_full_unstemmed |
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer |
title_sort |
pd-1 affects the immunosuppressive function of group 2 innate lymphoid cells in human non-small cell lung cancer |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-06-01 |
description |
BackgroundThere is increasing evidence that group 2 innate lymphoid cells (ILC2s) play an essential role in allergy and parasitic infection. However, the role of ILC2s in human lung cancer remains unclear.MethodsILC2s from peripheral blood mononuclear cells (PBMCs) obtained from healthy donors (HDs) and non-small cell lung cancer (NSCLC) patients, and NSCLC tumor tissues were analyzed via multicolor flow cytometry. ILC2s or CD14+ cells were sorted by fluorescence-activated cell sorting. qPCR and flow cytometry were performed to assess the gene and protein expression of the indicated molecules. M1-like and M2-like macrophages were induced from CD14+ monocytes in vitro.ResultsILC2s were significantly more enriched in PBMCs and tumor tissues from NSCLC patients than in HDs. After screening for the main immune checkpoint molecules, we found that PD-1 was upregulated in ILC2s in NSCLC patients. Functionally, PD-1high ILC2s from tumor tissues expressed higher levels of IL-4 and IL-13 regarding both mRNA and protein levels than PD-1low ILC2s. Furthermore, PD-1high ILC2s robustly boosted M2-like macrophage polarization in vitro, by secreting IL-4 and IL-13, while neutralization of IL-4 and IL-13 by antibodies abrogated M2-like macrophage polarization.ConclusionILC2s are enriched in NSCLC patients and upregulate PD-1 expression. Upregulation of PD-1 facilitates the immunosuppressive function of ILC2s. PD-1high ILC2s enhance M2-like macrophage polarization by secreting IL-4 and IL-13. PD-1 acts as a positive regulator of the immunosuppressive function of ILC2s in human NSCLC. |
topic |
innate immune response non-small cell lung cancer programmed cell death protein 1 group 2 innate lymphoid cells type 2 macrophage |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.680055/full |
work_keys_str_mv |
AT chunyishen pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT chaojunliu pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT zhenzhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT zhenzhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT yuping pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT jingwenshao pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT yongguitian pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT weinayu pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT guohuiqin pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT guohuiqin pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT shashaliu pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT lipingwang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT yizhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT yizhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer AT yizhang pd1affectstheimmunosuppressivefunctionofgroup2innatelymphoidcellsinhumannonsmallcelllungcancer |
_version_ |
1721378195324796928 |